MedTrace Logo

Induce (Intellin Diabetic Foot) Feasibility Study

NCT03591081 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 19

Last updated 2020-08-20

No results posted yet for this study

Summary

This is a novel feasibility study to test the participant acceptance and usability of a specifically designed smart phone app. It will also explore the effects of smart phone technology in improving self-referrals into the diabetic foot ulcer (DFU) service. Furthermore, it will be explored if this increase in self-referrals will influence the outcome of people with diabetes who have recently had a healed foot ulceration.

Conditions

  • Healed Ulcer

Interventions

OTHER

Intellin smart phone application

This feasibility study will explore if creating an electronic platform Intellin smart phone application can promote and support timely self-referral for individuals with a recently healed DFU. It will explore the software applications acceptance and ease of use for patients.

Sponsors & Collaborators

  • Innovate UK

    collaborator OTHER_GOV

  • Gendius Ltd

    collaborator INDUSTRY

  • Natalie Garratt

    lead OTHER

Principal Investigators

  • Joanne McCardle · Northern Care Alliance NHS Foundation Trust

Study Design

Allocation
NA
Purpose
PREVENTION
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2018-06-22
Primary Completion
2020-03-20
Completion
2020-03-20

Countries

  • United Kingdom

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03591081 on ClinicalTrials.gov